GlobalData on MSN
NAMSA acquires Labcorp’s medical device testing assets
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
Already a monolith in the clinical testing space, Labcorp is aiming to further swell its testing capabilities with the acquisition of contract research organization Toxikon. The CRO provides ...
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. The Food and Drug Administration gave emergency authorization Tuesday to the first at-home novel ...
BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp, a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid ...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, is making its LabCorp 2019 Novel Coronavirus (COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results